Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (AVDL)

CUSIP: 05337M104

Q2 2020 13F Holders as of 30 Jun 2020

Security type / class
Equity / American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share
Total 13F shares
36,267,175
Total 13F value
$293,031,072
Holder snapshot 6 visible 7 signals
Share change
+9,069,807
Put/Call ratio
94%
SEC-reported price per share
$8.08
Number of holders
73
Value change
+$73,438,051
Number of buys
54
Open additional details 1 more signal available
Number of sells
20
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
98,762,388

Security key

05337M104

Report period

Q2 2020

Institutions

73

Top holders

10

AVDL full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2020 Previous quarter: Q1 2020 AVADEL PHARMACEUTICALS PLC SEC filings AVADEL PHARMACEUTICALS PLC company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of AVDL - Avadel Pharmaceuticals plc - American Depositary Shares, each representing one Ordinary Share, nominal value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
RTW INVESTMENTS, LP
Disclosed value leader
RTW INVESTMENTS, LP
Comparable rows
15/15
Latest evidence
31 Mar 2020
13F Lead comparable stake: 4.7% Showing 1-6 of 15 holder rows.

Quick read

RTW INVESTMENTS, LP leads the comparable SEC ownership view at 4.7%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RTW INVESTMENTS, LP's linked filing trail.
Comparable ownership Top 5
RTW INVESTMENTS, LP 4.7%
Avoro Capital Advisors LLC 4.4%
Vivo Capital, LLC 3.6%
ACUTA CAPITAL PARTNERS, LLC 2.7%
BRANDES INVESTMENT PARTNERS, LP 1.7%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
RTW INVESTMENTS, LP
13F
Company
13F
4.7%
$36,253,000
4,616,570 shares
 — 31 Mar 2020
Avoro Capital Advisors LLC
13F
Company
13F
4.4%
$34,663,000
4,365,655 shares
 — 31 Mar 2020
Vivo Capital, LLC
13F
Company
13F
3.6%
$28,389,000
3,575,424 shares
 — 31 Mar 2020
ACUTA CAPITAL PARTNERS, LLC
13F
Company
13F
2.7%
$20,949,000
2,673,718 shares
 — 31 Mar 2020
BRANDES INVESTMENT PARTNERS, LP
13F
Company
13F
1.7%
$13,012,000
1,638,838 shares
 — 31 Mar 2020
COWEN AND COMPANY, LLC
13F
Company
13F
1.5%
$10,767,000
1,517,296 shares
 — 31 Mar 2020
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2020

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
73
Shares
36,267,175
Rows available
73
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders
55
Q2 2020 holders
73
Holder diff
18
Investor Q1 2020 Shares Q2 2020 Shares Share Diff Share Chg % Q1 2020 value Q2 2020 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .